COVID-19 update included
The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic

The Europe Hybrid Imaging Market would witness market growth of 4.04% CAGR during the forecast period (2019-2025).
The use of hybrid imaging in the diagnosis of diseases across different medical fields, including oncology, cardiology, and neurology, has risen sharply in recent years. This results in a growing demand for qualified professionals to capture and understand the data generated by these tools. Thus, numerous institutes and research centers are undertaking multimodal imaging training programs. In the regional market, Europe obtained a larger share in the market for hybrid imaging. The increasing emphasis on creating multimodal imaging in the region is expected to drive the demand in Europe. The European Society for Hybrid, Molecular and Translational Imaging (ESHIMT) is a non-profit organization established in Europe to encourage and organize the professional activities of people working in the field of hybrid imaging. The organization organizes several educational and training programs for doctors, scientists, physicists, technologists, radiographers, and others in the field.
Western Europe recorded an exponential boost in PET/CT scans in 2018. That being said, the installation statistics of SPECT/CT systems increased gradually as compared to PET/CT installations. Government initiatives to build multimodal or hybrid diagnostic imaging technologies are expected to drive the market. For example, European Cooperation in Science and Technology (COST), a government-funded group that helps in the development of research networks, inaugurated a program called Correlated Multimodal Imaging in Life Sciences (COMULIS).
Based on Application, the market is segmented into Oncology, Ophthalmology, Cardiology, Brain & Neurology, and Other Applications. Based on Type, the market is segmented into PET/CT systems, SPET/CT systems, PET/MR systems, OCT/Fundus Imaging System and Other types. Based on End Use, the market is segmented into Hospitals, Diagnostic Imaging Centers and Other End Use. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Siemens AG (Siemens Healthineers), Canon, Inc. (Canon Medical Systems Corporation), General Electric (GE) Co. (GE Healthcare), Hitachi, Ltd. (Hitachi Healthcare), Koninklijke Philips N.V., PerkinElmer, Inc., Bruker Corporation, Atlantis Worldwide, LLC.
Scope of the Study
Market Segmentation:
By Application

  • Oncology
  • Ophthalmology
  • Cardiology
  • Brain & Neurology
  • Other Applications


By Type

  • PET/CT systems
  • SPET/CT systems
  • PET/MR systems
  • OCT/Fundus Imaging System
  • Other types


By End User

  • Hospitals
  • Diagnostic Imaging Centers
  • Other End Use


By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe


Companies Profiled

  • Siemens AG (Siemens Healthineers)
  • Canon, Inc. (Canon Medical Systems Corporation)
  • General Electric (GE) Co. (GE Healthcare)
  • Hitachi, Ltd. (Hitachi Healthcare)
  • Koninklijke Philips N.V.
  • PerkinElmer, Inc.
  • Bruker Corporation
  • Atlantis Worldwide, LLC
  • Cubersa, Inc.
  • Amber Diagnostics, Inc.


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free